Gallacher Capital Management LLC Bio N Tech Se Transaction History
Gallacher Capital Management LLC
- $218 Billion
- Q3 2024
A detailed history of Gallacher Capital Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Gallacher Capital Management LLC holds 2,180 shares of BNTX stock, worth $264,128. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,180
Previous 3,657
40.39%
Holding current value
$264,128
Previous $294 Million
11.9%
% of portfolio
0.12%
Previous 0.15%
Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
359Shares Held
38.5MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.01 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$547 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$528 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$230 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$219 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...